Literature DB >> 17324972

Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis.

Vinod Chandran1, Sita Bhella, Catherine Schentag, Dafna D Gladman.   

Abstract

BACKGROUND: Fatigue is an important symptom in psoriatic arthritis (PsA). AIM: To determine the reliability and validity of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT fatigue) Scale in PsA.
METHODS: Consecutive patients attending the PsA clinic were assessed with the FACIT fatigue Scale twice, 1 week apart. Patients were assessed clinically according to a standardised PsA clinic protocol. Internal consistency of the 13 items on the FACIT fatigue questionnaire was measured using Cronbach's alpha; test-retest reliability by the intraclass correlation coefficient (ICC), and validity by the correlation of the FACIT fatigue results with other fatigue measures and disease characteristics.
RESULTS: 135 patients (80 men and 55 women, mean (SD) age 52 (13) years, mean (SD) disease duration 17 (10) years) participated. The mean FACIT fatigue score was 35.8 (12.4). Cronbach's alpha was 0.96. Repeat questionnaires were returned by 54% of patients. No difference in disease characteristics was observed between those who did and did not return the questionnaires. The ICC for first and repeat FACIT fatigue scores was 0.95. The correlation between the FACIT fatigue and modified Fatigue Severity Score was -0.79 (95% CI -0.85 to -0.72). FACIT fatigue scores were lower in patients with overwhelming fatigue and fibromyalgia than in those without (p<0.001). The FACIT fatigue was correlated with the actively inflamed joint count (-0.43, 95% CI -0.56 to -0.28, p<0.001), but not with the clinically damaged joint count (-0.06, 95% CI -0.23 to 0.11, p = 0.51).
CONCLUSION: The FACIT fatigue results were reproducible, and correlated with other fatigue measures as well as with disease activity in patients with PsA. Therefore, the FACIT fatigue is a reliable and valid instrument to measure fatigue in PsA.

Entities:  

Mesh:

Year:  2007        PMID: 17324972      PMCID: PMC1955111          DOI: 10.1136/ard.2006.065763

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Impact of fatigue on health-related quality of life in rheumatoid arthritis.

Authors:  Ines Rupp; Hendriek C Boshuizen; Catharina E Jacobi; Huibert J Dinant; Geertrudis A M van den Bos
Journal:  Arthritis Rheum       Date:  2004-08-15

3.  Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Authors:  Stanley B Cohen; Paul Emery; Maria W Greenwald; Maxime Dougados; Richard A Furie; Mark C Genovese; Edward C Keystone; James E Loveless; Gerd-Rüdiger Burmester; Matthew W Cravets; Eva W Hessey; Timothy Shaw; Mark C Totoritis
Journal:  Arthritis Rheum       Date:  2006-09

4.  Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study.

Authors:  T P Suurmeijer; M Waltz; T Moum; F Guillemin; F L van Sonderen; S Briançon; R Sanderman; W J van den Heuvel
Journal:  Arthritis Rheum       Date:  2001-04

5.  Fatigue in cancer patients compared with fatigue in the general United States population.

Authors:  David Cella; Jin-Shei Lai; Chih-Hung Chang; Amy Peterman; Mitchell Slavin
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

6.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

7.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

8.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

9.  Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients.

Authors:  Frederick Wolfe
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

10.  Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Authors:  Michael E Weinblatt; Edward C Keystone; Daniel E Furst; Larry W Moreland; Michael H Weisman; Charles A Birbara; Leah A Teoh; Steven A Fischkoff; Elliot K Chartash
Journal:  Arthritis Rheum       Date:  2003-01
View more
  52 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

2.  Validation of the Portuguese version of functional assessment of cancer therapy-fatigue (FACT-F) in Brazilian cancer patients.

Authors:  Neli Muraki Ishikawa; Luiz Claudio Santos Thuler; Alessandra Grasso Giglio; Clarissa Seródio da Rocha Baldotto; Carlos José Coelho de Andrade; Sophie Françoise Mauricette Derchain
Journal:  Support Care Cancer       Date:  2009-07-23       Impact factor: 3.603

3.  Metabolic Rate and Perceived Exertion of Walking in Older Adults With Idiopathic Chronic Fatigue.

Authors:  Vincenzo Valiani; Duane B Corbett; Jeffrey D Knaggs; Todd M Manini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-06-06       Impact factor: 6.053

Review 4.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

5.  Indicators and correlates of psychological disturbance in Chinese patients receiving maintenance hemodialysis: a cross-sectional study.

Authors:  Si-Yuan Wang; Xiao-Ying Zang; Jun-Duo Liu; Mei Cheng; Yue-Xian Shi; Yue Zhao
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

6.  The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension.

Authors:  Halil Onder; Ersin Kasim Ulusoy; Memet Aslanyavrusu; Tulin Akturk; Guven Arslan; Ibrahim Akkurt; Erol Erkan
Journal:  Neurol Sci       Date:  2020-05-26       Impact factor: 3.307

7.  Feasibility and Safety of Intradialysis Yoga and Education in Maintenance Hemodialysis Patients.

Authors:  Gurjeet S Birdee; Russell L Rothman; Stephanie J Sohl; Dolphi Wertenbaker; Amy Wheeler; Chase Bossart; Oluwaseyi Balasire; T Alp Ikizler
Journal:  J Ren Nutr       Date:  2015-04-11       Impact factor: 3.655

8.  [Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

Review 9.  Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors.

Authors:  Manisha Jhamb; Steven D Weisbord; Jennifer L Steel; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

10.  Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study.

Authors:  Joel Shi Quan Tan; Warren Fong; Yu Heng Kwan; Ying Ying Leung
Journal:  Rheumatol Int       Date:  2020-08-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.